BIA Separations is now part of Sartorius. Learn more

4th Gene Therapy for Rare Disorders USA - digital event

The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.

On Day One (February 23) our CEO, Ales Strancar's will present:

4:30 pm EST | 3rd Generation AAV Manufacturing Platform & In-Process Controls

  • from
    23Feb2021
    until
    24Feb2021
  • 4th Gene Therapy for Rare Disorders USA - digital event